SCHEMBL10501336

SCHEMBL10501336

COc1cccc(-n2[se]c3ccccc3c2=S)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 5/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ PMM2 O15305 2/20 0.42
▸ MPI P34949 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ PKM P14618 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ QSOX1 O00391 1/20 0.41
▸ RGS12 O14924 1/20 0.41
▸ PLIN1 O60240 1/20 0.41
▸ GMNN O75496 1/20 0.41
▸ BBOX1 O75936 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYBB P04839 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502310 0.88 METAP2 (0.52) METAP2PMM2MPIALDH1A1PKM
SCHEMBL10502111 0.85 METAP2 (0.68) METAP2SMN1; SMN2PMM2MPIALDH1A1
SCHEMBL10501830 0.84 METAP2 (0.48) METAP2SMN1; SMN2PMM2MPIALDH1A1
SCHEMBL10503543 0.82 METAP2 (0.50) METAP2SMN1; SMN2PMM2MPIALDH1A1
SCHEMBL10501563 0.82 METAP2 (0.74) METAP2PMM2MPIALDH1A1PKM
SCHEMBL10502481 0.82 METAP2 (0.46) METAP2PMM2MPIALDH1A1PKM
SCHEMBL10501995 0.81 METAP2 (0.47) METAP2
SCHEMBL10501743 0.79 METAP2 (0.54) METAP2ALDH1A1PKMKDM4ELMNA
SCHEMBL10500974 0.79 METAP2 (0.54) METAP2ALDH1A1KDM4ELMNAMAPT
SCHEMBL10501589 0.79 METAP2 (0.61) METAP2PMM2MPIALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback